MEDICINOVA, INC. Increase (Decrease) in Receivables
MEDICINOVA, INC. (MNOV) reported Increase (Decrease) in Receivables of -$6.01 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2017-02-14
- MEDICINOVA, INC. increase (decrease) in receivables for the quarter ending 2014-12-31 was $0.00.
- MEDICINOVA, INC. increase (decrease) in receivables for the quarter ending 2014-09-30 was $0.00.
- MEDICINOVA, INC. increase (decrease) in receivables for the quarter ending 2014-06-30 was $0.00.
- MEDICINOVA, INC. increase (decrease) in receivables for the quarter ending 2014-03-31 was -$6.01M.
- MEDICINOVA, INC. increase (decrease) in receivables for fiscal 2014 was -$6.01M, a 200.00% decline from fiscal 2013.
- MEDICINOVA, INC. increase (decrease) in receivables for fiscal 2013 was $6.01M.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | $0.00 derived: sum of 3 quarters · filed 2017-02-14 | -$6.01M 10-K · filed 2017-02-14 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $0.00 derived: sum of 2 quarters · filed 2015-10-29 | -$6.01M 10-Q · filed 2015-10-29 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$6.01M 10-Q · filed 2015-07-30 | ||
| 2014-03-31 | -$6.01M 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $6.01M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |